// App-Quantinova.ai

3034 : Dose-seeking phase I trials (DSP1T) for currently approved molecular-targeted therapies (MTT): We are still far from using appropriate designs.

Researchers

Presenter

  • Nuria Kotecki

Principal Investigators

  • Ahmad Awada

  • Jacques Bonneterre

  • Alexis B. Cortot

  • Sophie Cousin

  • Stephanie Clisant

  • Alain Duhamel

  • Andrew Kramar

  • Nicolas Penel

Medical Centers

  • Medical Oncology Unit - Hopital Huriez, Lille, France

  • Centre Oscar Lambret, Universite Lille Nord de France, Lille, FranceMedical Oncology Dpt, Centre Oscar Lambret, Lille, FranceCentre Hospitalier Regional Universitaire Lille, Lille, France

  • Centre Oscar Lambret, Lille, France

  • CERIM - Centre dEtudes et de Recherche en Informatique Medicale, Lille, France

  • Institut Jules Bordet, Universite libre de Bruxelles, Brussels, Belgium

  • Unite de Methodologie et Biostatistique, Centre Oscar Lambret, Lille, France

Locations

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Negative

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved